US 7285415
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted A61KA61K35/12A61P
Quick answer
US patent 7285415 (Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury) held by The Regents of the University of California expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K35/12, A61P, A61P25/00, A61P25/28